Celecoxib for rheumatoid arthritis

Author:

Garner Sarah E1,Fidan Dogan2,Frankish Ruth R3,Judd Maria4,Shea Beverley5,Towheed Tanveer6,Tugwell Peter7,Wells George A5

Affiliation:

1. National Institute for Health and Care Excellence (NICE); Science Policy and Research; MidCity Place 71 High Holborn London UK WC1V 6NA

2. Aventis Pharma Ltd.; Health Economics Unit; Flat 8 291 Boardwalk Place London UK E14 56E

3. National Institute for Clinical Excellence; Appraisals Team; 11 Strand London UK WC1N 5HR

4. Canadian Health Services Research Foundation/Fondation canadienne de la recherche sur les services de santé; Research Use/Agente principale de programme, Utilisation de la Recherche; 1565 avenue Carling Avenue Suite/pièce 700 Ottawa ON Canada K1Z 8R1

5. University of Ottawa; Department of Epidemiology and Community Medicine; 501 Smyth Road Ottawa ON Canada K1H 8L6

6. Queen's University; Department of Medicine and of Community Health and Epidemiology; Etherington Hall-Room 2066 Kingston ON Canada K7L 3N6

7. Faculty of Medicine, University of Ottawa; Department of Medicine; Ottawa ON Canada K1H 8M5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference36 articles.

1. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison;Emery;Lancet,1999

2. Efficacy and safety of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis [abstract];Geis;Arthritis & Rheumatism,1998

3. Serial endoscopies confirm lower incidence of gastroduodenal ulceration with celecoxib as compared to naproxen [abstract];Burr;American journal of Gastroenterology,1999

4. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase -2 inhibitor, compared to naproxen in patients with arthritis;Goldstein;American Journal of Gastroenterology,2001

5. Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis;A. J.;Aliment Pharmacol Ther,2004

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3